Honest scope for SignalForge
Independent portfolio prototype for evidence-grounded pharmaceutical competitive intelligence. Therapeutic focus: moderate-to-severe atopic dermatitis.
What is real
- Next.js public site + nine-area workbench with a seeded AD corpus
- Prisma + Neon PostgreSQL persistence with migrations, seed, and audit trail
- Demo session auth with server-side role checks on mutations (UI / onboarding persona alone is not the security boundary)
- Claim→evidence→source provenance, unsupported-claim gating, Ask Signal abstention
- Optional onboarding preferences persisted via Prisma (or labelled localStorage fallback)
What is mocked
- Ask Signal is not a live LLM — deterministic keyword matcher over the seed corpus
- No live proprietary APIs or real-time ingestion
- Safety cases are synthetic / fictional; mock human-review queue only
- Evaluation targets are illustrative; fixture runs measured against the seed corpus only
- Governance checklist items are requirements to validate, not certifications
Limitations
- Not a validated pharmacovigilance system
- Not for clinical decision support
- Not production-ready or regulatory-compliant
- Demo credentials are intentionally public
- Portfolio demo-ready — not pilot-ready (see repository AUDIT.md)